Preliminary observations indicate that DCI has beneficial effects in AD by counteracting the toxic actions of Abeta oligomers and by normalizing metabolic dysfunctions associated with amyloidosis in the humanized 5XFAD model of AD [24,25]. Here, APP is linked to Alzheimer disease.